Alcohol and Longevity: An Honest Conversation From Someone Who Loves Wine
Alcohol and Longevity: An Honest Conversation From Someone Who Loves Wine
I am writing this from Napa Valley, one of my favorite places on earth.
There is something genuinely beautiful about this place. The morning light on the vineyards, the quiet discipline of the growing season, the way a well-made wine carries the fingerprint of a specific hillside in a specific year. I spent five years making wine myself, and I loved every part of it — the farming, the chemistry, the patience, the art of it. I still love coming here.
And yet, sitting here with a glass of cabernet, I find myself thinking about the same question my patients increasingly ask me, and that I increasingly ask myself: is this worth it?
Not morally. Not in terms of judgment or abstinence or sobriety culture. But practically, honestly, and with the same rigor I try to bring to every other health decision in my life. Is what I am getting from this glass worth what I am giving up?
That is the conversation I want to have.
The "Everything in Moderation" Problem
We have all heard it. Everything in moderation. It is the most common piece of dietary advice in the English language, and in the context of alcohol it has functioned for decades as both a social permission slip and a medical reassurance.
The problem is that moderation is not a clinical category. It is a culturally negotiated comfort zone that means different things to different people, and it has allowed generations of physicians, including me, to sidestep a harder conversation.
The honest clinical position on alcohol is this: from a purely physiological standpoint, the optimal amount of alcohol for human health is zero. That is not a moralistic statement. It is what the evidence, when read carefully and without the filter of what we want it to say, actually supports.
That does not mean everyone should abstain. Life is not a purely physiological optimization problem. But it does mean that if you are drinking, you are making a tradeoff. And you deserve to understand exactly what you are trading.
The Collapse of the J-Curve
For decades, the dominant narrative in medicine was that moderate alcohol consumption, particularly red wine, offered cardiovascular protection. The J-curve hypothesis suggested that light to moderate drinkers had better heart health outcomes than both heavy drinkers and abstainers. This finding was replicated across dozens of observational studies and became so embedded in medical culture that many physicians actively recommended a glass of wine with dinner.
It was a compelling story. It was also largely wrong.
The J-curve findings suffered from a fundamental methodological problem known as the sick quitter bias. Many studies categorized former drinkers, people who had quit alcohol because of illness, as abstainers. When you compare moderate drinkers to a reference group that includes people who stopped drinking because they were already sick, moderate drinkers look healthier by comparison. The comparison was never fair.
When researchers began using Mendelian randomization, a genetic analysis method that can establish causation rather than just correlation by using naturally occurring genetic variants as proxies for alcohol exposure, the J-curve disappeared. A landmark 2018 Lancet analysis of data from 195 countries and nearly 700 studies concluded that the safest level of alcohol consumption is zero drinks per week. A major 2022 JAMA Network Open study using Mendelian randomization found no evidence of cardiovascular protection from moderate drinking after controlling for the sick quitter bias.
The cardiovascular benefit of moderate alcohol consumption is not supported by the best available evidence. It was a statistical artifact that we wanted to be true, and for a long time we let that desire shape our interpretation of the data.
What Alcohol Actually Does
Understanding alcohol's effects on the body requires looking at several interconnected systems. The picture that emerges is one of cumulative, dose-dependent biological cost that most moderate drinkers are not fully aware of.
Sleep
This is where I feel it most personally, and where my patients most often notice the effects of alcohol before anything else.
Alcohol is sedating. It helps people fall asleep faster. This is why so many people use it as a wind-down tool, and why the association between alcohol and sleep feels positive in the short term.
What is actually happening is something different. Alcohol suppresses REM sleep, the stage of sleep critical for memory consolidation, emotional regulation, and cognitive restoration. It also fragments sleep architecture in the second half of the night as the liver metabolizes the alcohol, leading to lighter, more disrupted sleep even when total sleep duration appears normal.
The result is that alcohol reliably degrades sleep quality even when it appears to be aiding sleep onset. A night of drinking followed by what feels like a full night of sleep is often a night of significantly impaired recovery. Wearable data from devices like the Oura ring has made this visible to patients in a way that clinical description alone never could. The conversation in my practice has shifted: patients no longer ask me whether alcohol affects sleep in theory. They show me their data.
For anyone serious about cognitive performance, physical recovery, or longevity, the sleep disruption from even moderate alcohol consumption is one of the most tangible and consequential effects in the evidence base.
Cardiovascular Risk
While the cardiovascular protection myth has largely collapsed, the cardiovascular risks of alcohol, even at moderate levels, are well established.
Atrial fibrillation is the most clearly documented. Even light to moderate drinking is associated with a meaningfully increased risk of AF. The association is dose-dependent and has been replicated in large prospective studies. For someone already at elevated cardiovascular risk, this is a clinically significant consideration.
Alcohol raises blood pressure in a dose-dependent fashion. It contributes to atherogenic dyslipidemia through its effects on triglycerides and HDL metabolism. It promotes systemic inflammation through multiple pathways, including gut permeability and endotoxin translocation, which over time contributes to accelerated vascular aging.
The net cardiovascular picture of moderate alcohol consumption is not neutral. It is modestly harmful, with the magnitude of harm scaling with consumption and baseline cardiovascular risk.
Cancer Risk
This is the piece of the alcohol conversation that is most consistently underappreciated, including by physicians.
Alcohol is a Group 1 carcinogen, the highest classification used by the International Agency for Research on Cancer. It is causally linked to cancers of the mouth, throat, esophagus, liver, colon, rectum, and breast. The association with breast cancer in particular is dose-dependent starting at very low levels of consumption, with no threshold below which risk disappears.
Alcohol is metabolized to acetaldehyde, a toxic compound that directly damages DNA. It also promotes cancer through multiple other mechanisms including oxidative stress, disruption of folate metabolism, and hormonal effects. These mechanisms operate at any level of consumption, not just heavy drinking.
The cancer risk from alcohol is the strongest argument against the idea that light drinking is biologically benign. It is not. The dose-response relationship begins at the first drink.
Metabolic and Body Composition Effects
Alcohol preferentially drives fat storage into the visceral compartment, the metabolically dangerous fat surrounding the organs that I have written about separately. This effect occurs independently of total caloric intake. A lean, disciplined person who exercises regularly and drinks moderately can accumulate meaningful amounts of visceral fat through this mechanism alone, with all the accompanying metabolic consequences: insulin resistance, inflammatory signaling, atherogenic lipid profiles, and cardiovascular risk.
Alcohol also disrupts the hormonal environment in ways that matter for metabolic health. It suppresses testosterone, elevates cortisol, and interferes with growth hormone secretion, particularly during sleep. For anyone focused on body composition, recovery, or healthy aging, these hormonal effects compound over time in ways that are easy to miss on standard laboratory panels but visible in how people look, feel, and perform.
The Gut
Alcohol increases intestinal permeability, allowing bacterial products to cross from the gut into systemic circulation. This drives low-grade endotoxemia and systemic inflammation that affects the liver, the cardiovascular system, and the brain. It disrupts the composition and diversity of the gut microbiome in ways that have downstream effects on immune function, metabolic health, and inflammation.
These effects occur at moderate levels of consumption and represent one of the less-discussed mechanisms through which alcohol contributes to chronic disease over time.
The Spectrum, Not the Binary
Here is where I want to be honest about something.
I am not writing this as an argument for universal abstinence. I am writing it as an argument for clarity. There is a significant difference between those two things.
Alcohol is woven into the fabric of human social life in ways that are not trivial. Sharing a bottle of wine over a long dinner with people you love, celebrating with a glass of champagne, the ritual pleasure of a well-made drink in a beautiful setting — these are real human experiences with real value. They are not nothing. They are part of what makes a life feel lived rather than merely optimized.
The question I sit with, and that I encourage my patients to sit with honestly, is not whether alcohol is good or bad in some absolute sense. It is whether the specific role alcohol plays in their specific life is worth the specific biological cost they are paying for it.
That is a genuinely personal calculation, and I do not think there is a universal right answer.
What I do think is that the calculation deserves to be made honestly, with accurate information, rather than with the comfortable fiction that moderate drinking is probably fine or that a glass of red wine is good for your heart. The evidence does not support those reassurances anymore.
From a purely clinical standpoint, no alcohol is better than some alcohol. Occasional drinking is meaningfully better than regular drinking. And the claimed benefits of moderate consumption, the cardiovascular protection, the stress relief, the social lubrication, are not a sufficient medical reason to recommend drinking to someone who does not already drink.
But if you drink, and you find genuine value in it, the goal is not shame or abstinence. It is honesty. What are you actually getting? What are you actually giving up? And is that a trade you are making deliberately, with clear eyes, rather than one you are making by default because everyone around you does the same?
A Personal Note
I am sitting in Napa Valley as I write this, and I will probably have a glass of wine with dinner tonight. Not because I think it is good for me. Not because I have convinced myself that the benefits outweigh the costs. But because I have decided, with clear eyes, that the experience is worth the tradeoff on this particular evening, in this particular place, with the people I am with.
That is a choice I am making deliberately. And that, I think, is exactly the point.
The goal of honest medicine is not to take pleasure out of life. It is to make sure that when we choose pleasure over optimization, we are doing so consciously and honestly, rather than because we have told ourselves a story that lets us have both.
I love wine. I also know what it costs me. Both of those things can be true at the same time.
References
GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015-1035.
Biddinger KJ, Emdin CA, Haas ME, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Network Open. 2022;5(3):e223849.
Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
Sabia S, Elbaz A, Britton A, et al. Alcohol consumption and cognitive decline in early old age. Neurology. 2014;82(4):332-339.
International Agency for Research on Cancer. Alcohol Consumption and Ethyl Carbamate. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2010;96.
Cao Y, Willett WC, Rimm EB, Stampfer MJ, Giovannucci EL. Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ. 2015;351:h4238.
Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA. Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis. Circulation. 2016;133(10):979-987.
Traversy G, Chaput JP. Alcohol Consumption and Obesity: An Update. Current Obesity Reports. 2015;4(1):122-130.
Colrain IM, Nicholas CL, Baker FC. Alcohol and the sleeping brain. Handbook of Clinical Neurology. 2014;125:415-431.
Bishehsari F, Magno E, Swanson G, et al. Alcohol and Gut-Derived Inflammation. Alcohol Research: Current Reviews. 2017;38(2):163-171.
Dr. Schraga is a concierge physician at Crescendo MD in Portola Valley, California, specializing in preventive and longevity medicine for executives and families in Silicon Valley.
